Contact Us Suppport HCC Webmail
ADVERTISEMENT

Custom Search
Today's Health Headlines
MBANDAKA, Democratic Republic of Congo (Reuters) - Congo began administering an experimental Ebola vaccine to medical staff in the northwestern city of Mbandaka on Monday to tackle an outbreak of the virus believed to have killed 26 people since early April.

LONDON (Reuters) - Roche's new hemophilia drug Hemlibra dramatically reduced bleeding in a broad population of hemophilia patients, results from two clinical trials showed on Monday, setting it up to take a dominant market position.

(Reuters) - The U.S Food and Drug Administration said on Monday it had approved Dova Pharmaceuticals Inc's drug to treat low blood platelet count in chronic liver disease (CLD) patients, who are scheduled to undergo a medical procedure.

(Reuters Health) - Grip strength may be a better predictor of future health than some measurements doctors currently use to gauge risk, a large UK study suggests.

LONDON (Reuters) - The decision by U.S. regulators to finally approve AstraZeneca's much-delayed excess potassium drug Lokelma gives the group another new medicine launch, boosting its portfolio as it strives to offset declining sales of older products.

Egg a day tied to lower risk of heart disease
Mon, 21 May 2018 18:39:52 -0400
(Reuters Health) - People who eat an egg just about every day may have a lower risk of heart attack and stroke than individuals who don't eat eggs at all, a large Chinese study suggests.

More U.S. kids overdosing on ADHD drugs
Mon, 21 May 2018 16:01:56 -0400
(Reuters Health) - The surge in U.S. kids taking medication for attention-deficit hyperactivity disorder (ADHD) is having an unintended side effect, a new study suggests: more children and teens are overdosing on these drugs.

(Reuters Health) - Adding chiropractic care to standard medical care for low back pain may help reduce discomfort and disability, a U.S. study suggests.

HONG KONG (Reuters) - China is considering ending the limits it sets on the number of children a family can have, Bloomberg reported on Monday, citing people familiar with the matter.

(Reuters) - Nabriva Therapeutics Plc's antibiotic drug to treat a common form of pneumonia met the main goal of a key clinical trial, but concerns over its side effects sent the drug developer's shares down 13 percent on Monday.

Welcome Guest
Username: 
Password:
Not a member? Sign Up!
Browse RSS Feeds
click here when finished
Save Page Layout
Video
loading